| Document and Entity Information | 3 Months Ended | |
| Nov. 30, 2014 | Jan. 13, 2015 | |
| Document And Entity Information | ||
| Entity Registrant Name | MIX 1 LIFE, INC. | |
| Entity Central Index Key | 1501112 | |
| Document Type | 10-Q | |
| Document Period End Date | 30-Nov-14 | |
| Amendment Flag | FALSE | |
| Current Fiscal Year End Date | -23 | |
| Is Entity a Well-known Seasoned Issuer? | No | |
| Is Entity a Voluntary Filer? | No | |
| Is Entity's Reporting Status Current? | Yes | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Common Stock, Shares Outstanding | 11,369,111 | |
| Document Fiscal Period Focus | Q1 | |
| Document Fiscal Year Focus | 2015 |
| BALANCE SHEETS (Unaudited) (USD $) | Nov. 30, 2014 | Aug. 31, 2014 |
| Current Assets: | ||
| Cash and cash equivalents | $46,673 | $91,794 |
| Inventory, lower of cost or market, principally first-in, first-out | 461,102 | 580,607 |
| Accounts receivable | 241,164 | |
| Notes receivable | 234,900 | |
| Other current Assets | 51,695 | 27,963 |
| Total Current Assets | 1,035,534 | 700,364 |
| Fixtures and Equipment, net of accumulated depreciation of $620 at November 30, 2014 and $413 at August 31, 2014 | 5,168 | 5,375 |
| Ingredient Specifications, Branding, and Other Intangible Assets, net of accumulated amortization of $429,643 at November 30, 2014, and zero at August 31, 2014 | 19,450,357 | 19,880,000 |
| TOTAL ASSETS | 20,491,059 | 20,585,739 |
| Current Liabilities: | ||
| Accounts payable and accrued liabilities | 111,767 | 218,330 |
| Accounts payable - related parties | 263,458 | 349,038 |
| Notes payable - premium finance | 6,307 | 15,932 |
| Total Current Liabilities | 381,532 | 583,300 |
| 12% Senior Secured Convertible Debenture | 750,000 | 500,000 |
| Total Liabilities | 1,131,532 | 1,083,300 |
| Shareholders' Equity: | ||
| Common Stock, $0.001 par value, 100,000,000 shares authorized 11,418,740 and 10,880,796 shares issued and outstanding at November 30, 2014 and August 31, 2014 respectively | 11,419 | 10,881 |
| Additional paid-in-capital | 22,430,242 | 21,547,848 |
| (Deficit) accumulated during the development stage | -3,082,134 | -2,056,290 |
| Total Shareholders' Equity | 19,359,527 | 19,502,439 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $20,491,059 | $20,585,739 |
| BALANCE SHEETS (Parenthetical) (USD $) | Nov. 30, 2014 | Aug. 31, 2014 |
| Current Assets: | ||
| Fixtures and Equipment, net of accumulated depreciation of $620 at November 30, 2014 and $413 at August 31, 2014 | $620 | $413 |
| Ingredient Specifications, Branding, and Other Intangible Assets, net of accumulated amortization of $429,643 at November 30, 2014, and zero at August 31, 2014 | $429,643 | $0 |
| Current Liabilities: | ||
| Senior Secured Convertible Debenture | 12.00% | 0.00% |
| Stockholders' Equity | ||
| Common stock, par value | $0.00 | $0.00 |
| Common stock, shares authorized | 100,000,000 | 100,000,000 |
| Common stock, shares issued | 11,418,740 | 10,880,796 |
| Common stock, shares outstanding | 11,418,740 | 10,880,796 |
| STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 66 Months Ended | |
| Nov. 30, 2014 | Nov. 30, 2013 | Nov. 30, 2014 | |
| Statements Of Operations | |||
| Gross Sales | $242,476 | $244,480 | |
| Costs of goods sold | -212,040 | -218,806 | |
| Gross Margin | 30,436 | 25,674 | |
| Operating Expenses | |||
| Selling and marketing | 44,316 | 24,195 | 146,243 |
| Corporate general and administrative | 488,226 | 273,624 | 1,924,055 |
| Depreciation and amortization expense | 429,850 | 430,263 | |
| Total operating expenses | 962,392 | 297,819 | 2,500,561 |
| Loss from Operations | -931,956 | -297,819 | -2,474,887 |
| Other (Expenses) | |||
| Interest expense | -93,888 | -607,247 | |
| Loss before income taxes | -1,025,844 | -297,819 | -3,082,134 |
| Provision for Income Taxes | |||
| Net (Loss) | ($1,025,844) | ($297,819) | ($3,082,134) |
| Basic and fully diluted: | |||
| Weighted average number of shares outstanding | 11,154,682 | 9,770,000 | |
| (Loss) per share | ($0.09) | ($0.03) | |
| STATEMENTS OF CASH FLOW (USD $) | 3 Months Ended | 66 Months Ended | |
| Nov. 30, 2014 | Nov. 30, 2013 | Nov. 30, 2014 | |
| Cash flows from operating activities: | |||
| Net (loss) | ($1,025,844) | ($297,819) | ($3,082,134) |
| Adjustments to reconcile net (loss) to net cash used in operating activities: | |||
| Common stock issued for services | 29,655 | 71,500 | 66,935 |
| Common stock issued for services - related parties | 78,601 | 30,000 | 374,310 |
| Common stock issued for officers' and directors' fees | 17,504 | 84,000 | 166,503 |
| Common stock issued for interest | 2,502 | 2,502 | |
| Convertible note loan fees | 194,445 | ||
| Valuation of warrants on convertible debt | 74,920 | 350,716 | |
| Depreciation and Amortization | 429,850 | 430,263 | |
| Changes in Current Assets and Liabilities | |||
| Inventory | 119,505 | -461,102 | |
| Accounts receivable | -241,164 | -241,164 | |
| Notes receivable | -234,900 | -234,900 | |
| Other current assets | -23,732 | -51,695 | |
| Accounts payable and accrued liabilities | -106,563 | 111,767 | |
| Accounts payable - related parties | -85,580 | 89,726 | 263,458 |
| Net cash (used) in by operating activities | -965,246 | -22,593 | -2,110,096 |
| Purchase of office equipment | -5,788 | ||
| Net cash provided by (used in) investing activities | -5,788 | ||
| Cash flows from financing activities | |||
| Loans from Officer | 22,600 | 33,400 | |
| Repayments to officer | -30,400 | ||
| Convertible note proceeds | 250,000 | 750,000 | |
| Sale of common stock | 679,750 | 20,000 | 1,403,250 |
| Premium finance payments | -9,625 | 6,307 | |
| Net cash provided by financing activities | 920,125 | 42,600 | 2,162,557 |
| Net increase in cash and cash equivalents | -45,121 | 20,007 | 46,673 |
| Cash and cash equivalents, beginning of year | 91,794 | ||
| Cash and cash equivalents, end of year | 46,673 | 20,007 | 46,673 |
| Cash paid during the year for: | |||
| Interest | 16,466 | 49,060 | |
| Income Taxes | |||
| Non-cash investing and financing activities: | |||
| Common stock issued for purchase of Mix1 assets | 19,880,000 | ||
| Purchase of Mix1 assets | -19,880,000 | ||
| Forgiveness of debt - Officer | -3,000 | ||
| Forgiveness of debt contributed to capital | 3,000 | ||
| Cancellation of Common Stock | -3,333 | ||
| Cancellation of Common Stock - Paid in Capital | 3,333 | ||
| Cashless exercise of Warrants | 374 | ||
| Cashless exercise of Warrants - Paid in Capital | -374 | ||
| Total | |||
| Description of Business and Summary of Significant Accounting Policies | 3 Months Ended |
| Nov. 30, 2014 | |
| Notes to Financial Statements | |
| Note 1 - Description of Business and Summary of Significant Accounting Policies | Mix1 Life, Inc. (“the Company”) was incorporated under the laws of the State of Nevada, U.S. on June 10, 2009. The Company is in the development stage as defined under statement on Financial Accounting Standards Accounting Standards Codification FASB ASC 915-205 “Development-Stage Entities.” On August 27, 2013, the Company purchased all of the product specifications and branding of Mix1 nutritional products. |
| The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report filed with the SEC on its 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the audited financial statements for the year ended August 31, 2014, as reported in the Form 10-K, have been omitted. | |
| There financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has limited cash and, as yet, has not generated any substantial revenues, raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, sales, loans from investors and/or issuance of common shares. |
| Stock Transactions | 3 Months Ended |
| Nov. 30, 2014 | |
| Notes to Financial Statements | |
| Note 2 - Stock Transactions | During the three months ending November 30, 2014, the Company sold 453,167 shares of its common stock in private placements for $1.50 per share. There were 19,270 shares of common stock issued to non-related parties for various services rendered to the Company valued at $29,655, 52,401 shares of common stock issued to related parties as payroll and consulting fees valued at $78,601, and 834 shares of common stock issued as interest expense valued at $2,502. There were 11,669 shares issued as officer and directors fees valued at $17,504. |
| Note Receivable | 3 Months Ended |
| Nov. 30, 2014 | |
| Notes to Financial Statements | |
| Note 3 - Note Receivable | In October 2014, the Company loaned $234,900 to a beverage distributor and consulting firm with which it does business. The note is a 5 percent simple interest note due December 1, 2014. |
| Convertible Note | 3 Months Ended |
| Nov. 30, 2014 | |
| Notes to Financial Statements | |
| Note 4 - Convertible Note | During the three months ending November 30, 2014 the Company entered into a convertible debt agreement for $250,000. Terms of this transaction include annual interest rate of 12% due November 5th, 2016, the option to convert debt into equity at $3.00 per share, and 41,667 stock purchase warrants. The warrants were valued using the Black Scholes valuation method at $74,290 calculated using a stock price of $6.13, a 5 year term, risk-free rate of interest of 1.64% and a volatility of 17.37%. |
| Subsequent Events | 3 Months Ended |
| Nov. 30, 2014 | |
| Notes to Financial Statements | |
| Note 5 - Subsequent Events | We have evaluated events and transactions after the balance sheet date to the date these financials statements were released for filing. We did not have any material subsequent events that would require disclosure in these financial statements. |
| Stock Transactions (Details Narrative) (USD $) | 3 Months Ended |
| Nov. 30, 2014 | |
| Stock Transactions Details Narrative | |
| Sales of common stock | 453,167 |
| Sales of common stock private placement per share | $1.50 |
| Common stock issued to to non-related parties | 19,270 |
| Common stock issued to to non-related parties, Value | $29,655 |
| Common stock issued to related parties as payroll and consulting fees | 52,401 |
| Common stock issued to related parties as payroll and consulting fees, Value | 78,601 |
| Common stock issued as interest expense | 834 |
| Common stock issued as interest expense, Value | 2,502 |
| Shares issued as officer and directors fees | 11,669 |
| Shares issued as officer and directors fees, Value | $17,504 |
| Convertible Note (Details Narrative) (USD $) | 3 Months Ended |
| Nov. 30, 2014 | |
| Convertible Note Details Narrative | |
| Convertible debt agreement | $250,000 |
| Annual interest rate | 12.00% |
| Annual interest payable date | 5-Nov-16 |
| Option to convert debt into equity | $3 |
| Stock purchase warrants | 41,667 |
| Warants valued | $74,290 |
| Stock price | $6.13 |
| Contractual term | 5 years |
| Risk-free rate of interest | 1.64% |
| Volatility rate | 17.37% |
